evidenceinthewild:

Your linked thread suggests they are often recommended at oncology workshops when there aren’t enough resources to power a comparative trial — randomization retained as a kind of procedural legitimacy device even when comparison is abandoned.

I find it strange, even suspicious, that balanced/minimized designs are not recommended by biostatisticians in these particular cases…